Tech Center 1700 • Art Units: 1758 1777 1797
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17436218 | IN VIVO REVERSIBILITY OF HIGH MOLECULAR WEIGHT SPECIES | Non-Final OA | AMGEN INC. |
| 17089448 | Diagnostic Method | Final Rejection | Amazentis SA |
| 18221934 | ISOELECTRIC FOCUSING-BASED ENRICHMENT OF CHARGE VARIANT SPECIES | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17880676 | TARGET MATERIAL IDENTIFICATION METHOD | Non-Final OA | Taiwan Semiconductor Manufacturing Company, Ltd. |
| 18023483 | METHODS FOR FINE NEEDLE SAMPLE ANALYSIS VIA MASS SPECTROMETRY | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17079110 | Genetic Determination of Hormone Levels and Applications Thereof | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 19187629 | BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS | Final Rejection | MOONLAKE IMMUNOTHERAPEUTICS AG |
| 18043495 | URINARY GLYCOPROTEINS FOR THE EARLY DETECTION AND TREATMENT OF AGGRESSIVE PROSTATE CANCER | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 17633917 | BIOMARKERS FOR NEURODEGENERATIVE DISORDERS | Final Rejection | The Johns Hopkins University |
| 18027393 | CONTINUOUS OPTICAL APTAMER SENSORS | Non-Final OA | University Of Cincinnati |
| 17614140 | METHODS OF DETECTING CLOSTRIDIUM DIFFICILE INFECTIONS | Final Rejection | Washington University |
| 17787015 | ENDOTOXIN DETECTION | Non-Final OA | Eli Lilly and Company |
| 18014582 | ACQUISITION METHOD OF VALUE RELATING TO TRIGLYCERIDE METABOLIC CAPACITY, PRESENTATION METHOD OF DISEASE INFORMATION, PRESENTATION METHOD OF DISEASE DIFFERENTIATION INFORMATION, PRESENTATION METHOD OF THERAPY EFFICACY INFORMATION, PRESENTATION METHOD OF THERAPEUTIC EFFECT INFORMATION, TEST REAGENT AND TEST KIT | Non-Final OA | THE UNIVERSITY OF OSAKA |
| 18286403 | Sample Conveying Device, Sample Analysis System, and Sample Pretreatment System | Non-Final OA | Hitachi High-Tech Corporation |
| 17816076 | MONITORING AND MANAGEMENT OF CELL THERAPY-INDUCED TOXICITIES | Non-Final OA | Kite Pharma, Inc. |
| 17680195 | BIPHASIC COATINGS WITH CHEMICAL SENSING, AND METHODS OF MAKING AND USING THE SAME | Final Rejection | HRL Laboratories, LLC |
| 17259264 | SUGAR CHAIN SPECIFIC TO PROSTATE CANCER, AND TEST METHOD USING SAME | Non-Final OA | JAPANESE FOUNDATION FOR CANCER RESEARCH |
| 18026088 | METHODS OF DETECTING AND USING BIOMARKERS FOR GLYCOGEN STORAGE DISEASES | Final Rejection | Duke University |
| 17673987 | METHODS AND SYSTEMS FOR EVALUATING ORGANIC CONTAMINANTS IN WATER | Final Rejection | CHEMTREAT, INC. |
| 18147094 | USE OF BIOMARKERS TO DETERMINE SUB-ACUTE TRAUMATIC BRAIN INJURY (TBI) IN A SUBJECT HAVING RECEIVED A HEAD COMPUTERIZED TOMOGRAPHY (CT) SCAN THAT IS NEGATIVE FOR A TBI OR NO HEAD CT SCAN | Non-Final OA | Abbott Laboratories |
| 17027206 | CENTRIFUGE AND METHOD FOR LOADING A DEVICE | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 18763980 | PARTICLES AND METHODS OF ASSAYING | Non-Final OA | Seer, Inc. |
| 18306195 | DETECTION OF AN ANALYTE OF INTEREST BY NANOESI MASS SPECTROMETRY | Final Rejection | Roche Diagnostics Operations, Inc. |
| 18028235 | CIRCULATING TOTAL-NT-PROBNP (GLYCOSYLATED AND UNGLYCOSYLATED NT-PROBNP) AND ITS RATIO WITH NT-PROBNP (UNGLYCOSYLATED NT-PROBNP) IN THE ASSESSMENT OF ATRIAL FIBRILLATION | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18125708 | METHOD FOR DETERMINING THE LEVEL OF VITAMIN D AND METABOLITES THEREOF | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18669414 | METHOD, AN APPARATUS, AN ASSEMBLY AND A SYSTEM SUITABLE FOR DETERMINING A CHARACTERISTIC PROPERTY OF A MOLECULAR INTERACTION | Final Rejection | FIDA BIOSYSTEMS APS |
| 16978638 | SYSTEMS AND METHODS OF DIAGNOSING AND PROGNOSING CANCER | Non-Final OA | THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE |
| 18634737 | Chronic Disease Management Test to Inform Clinical Care of Patients with Chronic Conditions | Final Rejection | Aegis Sciences Corporation |
| 16766956 | DETECTION OF BIOMARKERS | Non-Final OA | Imperial College of Science, Technology and Medicine |
| 17907395 | PROGNOSTIC MARKERS OF DISEASE RECURRENCE IN LIVER TRANSPLANT RECIPIENTS WITH HEPATOCELLULAR CARCINOMA | Non-Final OA | Universiteit Gent |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy